Super gonorrhea has been reported in other countries, and public health and clinicians will have to work together to keep it out of the United States.
Despite a relatively low prevalence of these multidrug-resistant (MDR) strains of gonorrhea in the United States over the past three decades, a combination of surveillance and adherence to recommended therapy is necessary to delay further drug resistance from developing, according to a poster at the 2018 IDWeek (abstract 1167).
An